Hepatitis C Support Group
Hepatitis C is a blood-borne viral disease which can cause liver inflammation, fibrosis, cirrhosis and liver cancer. The hepatitis C virus (HCV) is spread by blood-to-blood contact with an infected person's blood. Many people with HCV infection have no symptoms and are unaware of the need to seek treatment. Hepatitis C infects an estimated 150-200 million people worldwide.
Aethlon Medical Announces FDA Approval of IDE to Treat Hepatitis C (HCV) Patients
SAN DIEGO, June 25, 2013 -- /PRNewswire/ -- Aethlon Medical, Inc. (OTCQB: AEMD), announced today that the United States Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) that allows the Company to initiate human feasibility studies of the Aethlon Hemopurifier in the United States. The Hemopurifier is a first-in-class medical device that targets the rapid elimination of life-threatening infectious disease and cancer glycopathogens from circulation.
http://www.sacbee.com/2013/06/25/5522204/aethlon-medical-announces-fda.html
SAN DIEGO, June 25, 2013 -- /PRNewswire/ -- Aethlon Medical, Inc. (OTCQB: AEMD), announced today that the United States Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) that allows the Company to initiate human feasibility studies of the Aethlon Hemopurifier in the United States. The Hemopurifier is a first-in-class medical device that targets the rapid elimination of life-threatening infectious disease and cancer glycopathogens from circulation.
http://www.sacbee.com/2013/06/25/5522204/aethlon-medical-announces-fda.html
I wish them great successes!
Remember this thread?
http://www.dailystrength.org/c/Hepatitis_C/forum/15497392-hemopurifier-filters-hcv-out
Most definitely an interesting thread to say the least! Lolololol!!!
Respectfully,
HANK
Respectfully,
HANK A.K.A. Enrique!
"In studies conducted in India, a three-treatment Hemopurifier protocol administered in combination with interferon-based SOC resulted in undetectable HCV levels in as little at seven days in hard to treat genotype-1 patients.
The studies also documented the ability of the Hemopurifier to capture as many as 300 billion copies of HCV during a single six-hour treatment.
In addition to augmenting the early viral kinetic response to drug therapy, the Hemopurifier is a candidate solution for viral rebound patients who traditionally are forced to discontinue therapy once HCV establishes resistance to their drug regimens.
Such a solution would address a significant unmet medical need in HCV care."
Where's the "like" button??? I mean SEVEN days???
Talk about leapfrogging back from what was previously the shortest length of treatment of 8 -12 weeks to now having the potential of clearing in ONE to TWO WEEKS???
NOW THAT"S WHAT I CALL PROGRESS!!! WOWWWW!!!
Respectfully,
HANK
http://www.aethlonmedical.com/assets/001/5050.pdf
I cannot wait for these trials for HCV begin!!! Especially when they combine this with the new DAA's that will soon be approved!!!
Man -O - MAN!!! I'm Psyched again!!!
Bring it!!!
Respectfully,
HANK
I fully believe this virus will very soon be eradicated from populations, like polio, something people will remember.
The Evolution of Therapeutic Filtration to Improve Hepatitis-C Virus (HCV) Treatment Outcomes:
http://www.aethlonmedical.com/assets/001/5047.pdf
A Platform Technology to Address Bioterrorism:
http://www.aethlonmedical.com/assets/001/5040.pdf
A Medical Device Strategy To Inhibit HER2+ Breast Cancer Progression:
http://www.aethlonmedical.com/assets/001/5080.pdf
A Novel Treatment Strategy for Ebola & Marburg Haemorrhagic Fevers:
http://www.aethlonmedical.com/assets/001/5017.pdf
Congressional Testimony of James A. Joyce (7/12/05):
http://www.aethlonmedical.com/assets/001/5023.pdf
Enjoy the readings! ;>)
Respectfully,
HANK